Paul Lambert
Gästprofessor
E-postadress: paul.lambert@ki.se
Besöksadress: Nobels väg 12a, 17165 Stockholm
Postadress: C8 Medicinsk epidemiologi och biostatistik, C8 MEB III, 171 77 Stockholm
Om mig
- Paul Lambert är gästprofessor i epidemiologi vid institutionen för
medicinsk epidemiologi och biostatistik, Karolinska Institutet.
Artiklar
- Article: CANCER EPIDEMIOLOGY. 2026;101:102999Lambert PC; Nilssen Y; Myklebust TA; Aagnes B; Moller B; Rutherford MJ
- Article: BMJ ONCOLOGY. 2026;5(1):e000999Stannard R; Lambert PC; Andersson TM-L; Khan S; Lyratzopoulos G; Syriopoulou E; Rutherford MJ
- Article: HAEMATOLOGICA. 2026;111(3):990-996Leontyeva Y; Landtblom AR; Hultcrantz M; Lambe M; Bower H; Lambert PC; Andersson TM-L
- Article: EUROPEAN JOURNAL OF EPIDEMIOLOGY. 2026;41(3):309-315Ahlqvist VH; Sjoqvist H; Sjolander A; Berglind D; Lambert PC; Lee BK; Madley-Dowd P
- Article: STATA JOURNAL. 2026;26(1):7-37Lambert PC; Rutherford MJ
- Article: BMC MEDICAL RESEARCH METHODOLOGY. 2026;26(1):60Timmins IR; Torabi F; Jackson CH; Lambert PC; Sweeting MJ
- Article: STATISTICS IN MEDICINE. 2026;45(1-2):e70376Leithe S; Moller B; Aagnes B; Nilssen Y; Lambert PC; Myklebust TA
- Article: HEART. 2025;:heartjnl-2025-326524Ow KW; Tyrer F; Van Den Berg F; Lai J; Vernon S; Paley L; Wenzl FA; Weston C; Rutherford MJ; Lambert PC; de Belder MA; Deanfield J; Peake MD; Adlam D
- Article: JOURNAL OF NEURO-ONCOLOGY. 2025;175(3):1355-1366Trewin-Nybraten CB; Lambert PC; Marienhagen K; Andreassen L; Johannesen TB; Niehusmann P; Oltedal L; Schipmann S; Skjulsvik AJ; Solheim O; Solheim TS; Sundstrom T; Vik-Mo EO; Brandal P; Ingebrigtsen T; Skaga E
- Article: DIAGNOSTIC AND PROGNOSTIC RESEARCH. 2025;9(1):23Mozumder SI; Booth S; Riley RD; Rutherford MJ; Lambert PC
- Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2025;34(7):1141-1148Lambert PC; Andersson TML; Myklebust TA; Moller B; Rutherford MJ
- Article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2025;54(4):dyaf082Larsen SB; Lundberg FE; Friis S; Birgisson H; Andersson TML; Engholm G; Lambert PC; Brasso K; Pettersson D; Olafsdottir E; Johannesen TB; Konig SM; Johansson ALV; Morch LS
- Article: JACC: CARDIOONCOLOGY. 2025;7(4):345-356Abiodun AT; Ju C; Welch CA; Lai J; Tyrer F; Chambers P; Paley L; Vernon S; Deanfield J; de Belder M; Rutherford MJ; Lambert PC; Slater S; Shiu K-K; Wei L; Peake MD; Adlam D; Manisty C
- Article: BRITISH JOURNAL OF CANCER. 2025;132(8):673-678Stannard R; Lambert PC; Lyratzopoulos G; Andersson TM-L; Khan S; Rutherford MJ
- Article: STATISTICS IN MEDICINE. 2025;44(6):e70035Jennings AC; Rutherford MJ; Lambert PC
- Article: BMJ ONCOLOGY. 2024;3(1):e000323Abiodun AT; Ju C; Welch CA; Lai J; Tyrer F; Chambers P; Paley L; Vernon S; Deanfield J; de Belder M; Rutherford M; Lambert PC; Slater S; Shiu KK; Wei L; Peake MD; Adlam D; Manisty C
- Article: LUNG CANCER. 2024;192:107826Lundberg FE; Ekman S; Johansson ALV; Engholm G; Birgisson H; Olafsdottir EJ; Morch LS; Johannesen TB; Andersson TM-L; Pettersson D; Seppa K; Virtanen A; Lambe M; Lambert PC
- Article: EUROPEAN JOURNAL OF CANCER. 2024;202:113980Lundberg FE; Birgisson H; Engholm G; Olafsdottir EJ; Morch LS; Johannesen TB; Pettersson D; Lambe M; Seppa K; Lambert PC; Johansson ALV; Holmichj LR; Andersson TM-L
- Article: ACTA ONCOLOGICA. 2024;63:179-191Johansson ALV; Konig SM; Laronningen S; Engholm G; Kroman N; Seppa K; Malila N; Steig BA; Gudmundsdottir EM; Olafsdottir EJ; Lundberg FE; Andersson TM-L; Lambert PC; Lambe M; Pettersson D; Aagnes B; Friis S; Storm H
- Article: VALUE IN HEALTH. 2024;27(3):347-355Jennings AC; Rutherford MJ; Latimer NR; Sweeting MJ; Lambert PC
- Visa fler
Alla övriga publikationer
- Preprint: MEDRXIV. 2025;MEDRXIVAhlqvist VH; Sjöqvist H; Sjölander A; Berglind D; Lambert PC; Lee BK; Madley-Dowd P
- Conference publication: EUROPEAN UROLOGY. 2024;85:s52Larsen SB; Lundberg FE; Friis S; Birgisson H; Andersson TML; Engholm G; Lambert PC; Lambe M; Pettersson D; Olafsdottir E; Johannesen TB; Konig SM; Johansson ALV; Morch LS
- Conference publication: HEART. 2023;109:A40-A41Ow KW; Van den Berg F; de Belder M; Deanfield J; Rutherford M; Peake M; Paley L; Adlam D; Lambert P; Tyrer F; Lai J
- Preprint: RESEARCH SQUARE. 2022Skourlis N; Crowther M; Andersson TM-L; Lu D; Lambe M; Lambert P
- Preprint: MEDRXIV. 2022Schmidt JCF; Lambert PC; Gillies C; Sweeting MJ
- Preprint: RESEARCH SQUARE. 2022Batyrbekova N; Bower H; Dickman PW; Landtblom AR; Hultcrantz M; Szulkin R; Lambert PC; Andersson TM-L
- Preprint: ARXIV. 2021Syriopoulou E; Mozumder SI; Rutherford MJ; Lambert PC
- Preprint: RESEARCH SQUARE. 2021Rutherford MJ; Andersson TM-L; Myklebust TÅ; Møller B; Lambert PC
- Preprint: RESEARCH SQUARE. 2021Skourlis N; Crowther MJ; Andersson TM-L; Lambert PC
- Preprint: RESEARCH SQUARE. 2021Batyrbekova N; Bower H; Dickman P; Szulkin R; Lambert PC; Andersson TM-L
- Preprint: ARXIV. 2020Weibull CE; Lambert PC; Eloranta S; Andersson TML; Dickman PW; Crowther MJ
- Preprint: RESEARCH SQUARE. 2020Lambert PC; Syriopoulou E; Rutherford MJ
- Review: CANCER EPIDEMIOLOGY. 2019;60:168-173Rutherford MJ; Andersson TM-L; Bjorkholm M; Lambert PC
- Letter: JOURNAL OF CLINICAL ONCOLOGY. 2017;35(6):696-697Bower H; Bjorkholm M; Dickman PW; Hoglund M; Lambert PC; Andersson TM-L
- Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2017;35(5):209Lambe M; Lambert P; Fredriksson I; Plym A
- Published conference paper: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(24):2851-2857Bower H; Bjorkholm M; Dickman PW; Hoglund M; Lambert PC; Andersson TM-L
- Published conference paper: STATISTICS IN MEDICINE. 2016;35(7):1193-1209Crowther MJ; Andersson TM-L; Lambert PC; Abrams KR; Humphreys K
- Conference publication: BLOOD. 2015;126(23):2779Bjorkholm M; Bower H; Dickman PW; Lambert PC; Hoglund M; Andersson TM-L
- Letter: STATISTICS IN MEDICINE. 2015;34(25):3378-3380Crowther MJ; Lambert PC
- Conference publication: HAEMATOLOGICA. 2015;100:193Bower H; Andersson TM-L; Bjorkholm M; Dickman P; Lambert P; Derolf A
- Visa fler
Forskningsbidrag
- Swedish Research Council1 januari 2022 - 31 december 2025
- Get the most out of cancer registry data: development and application of multistate modelsSwedish Cancer Society1 januari 2018Sweden has some of the best population-based cancer data in the world. An important advantage is the possibility of linking different databases, which leads to more detailed data that makes it possible to deal with more complex research questions. The increased complexity and details of the data lead to challenges with the statistical analyzes to ensure that the clinical research questions are answered in the most appropriate way. Estimating disease progression and survival after a cancer diagnosis, through the use of population-based registry data, is crucial to be able to track progress against cancer and identify risk factors associated with prognosis. With more detailed data, it is possible to use more sophisticated statistical methods. In this project, we will use and further develop methods called multistate models, which aim to give a deeper understanding of the course of the disease and how different risk factors are related to this. When statistical methods become more complex, it is important that the results are communicated in a way that is understandable and useful for patients, healthcare professionals and health care policy makers. This project will therefore further develop methods for presenting results that are easy to understand for those without technical background. It is important that new methods that are developed are made available to other researchers. We will therefore develop freely available software, collaborate with clinics and epidemiologists in studies that answer important clinical issues, and organize courses / workshops aimed at those who want to use the methods.
- Swedish Research Council1 januari 2018 - 31 december 2021
- Improve the quality of statistical methods used to analyze population-based cancer dataSwedish Cancer Society1 januari 2017Estimating survival after a cancer diagnosis using data from population-based cancer registers is important to be able to monitor the development of cancer and identify risk factors associated with prognosis. Sweden has, internationally, cancer register data of very high quality, and an important advantage is the possibility of merging different databases. This leads to more detailed information and enables studies with more complex issues. The increasing complexity and details of data, however, poses some challenges for statistical analysis to ensure that the clinical research questions are answered in the most appropriate manner. In this project we will develop statistical methods that can be used to answer important clinical issues using data from cancer registers. With more detailed information, it is possible to use more advanced statistical methods. However, it is important that the results of these analyzes are communicated in a way that is understandable and useful for patients, doctors and decision makers. Thus, this project will also ensure that even if the statistical methods are complex, it must be possible to present the results in a way so that the results are easy to understand for them without a technical background. We will develop statistical methods that help us understand the disease process after a cancer diagnosis and further understand the effect of any risk factors. We will also work with other cancer researchers to use the methods in applied research. We will also develop user-friendly software to enable other researchers to use our methods in their research.
- Improve the quality of statistical methods used to analyze population-based cancer dataSwedish Cancer Society1 januari 2016Estimating survival after a cancer diagnosis using data from population-based cancer registers is important to be able to monitor the development of cancer and identify risk factors associated with prognosis. Sweden has, internationally, cancer register data of very high quality, and an important advantage is the possibility of merging different databases. This leads to more detailed information and enables studies with more complex issues. The increasing complexity and details of data, however, poses some challenges for statistical analysis to ensure that the clinical research questions are answered in the most appropriate manner. In this project we will develop statistical methods that can be used to answer important clinical issues using data from cancer registers. With more detailed information, it is possible to use more advanced statistical methods. However, it is important that the results of these analyzes are communicated in a way that is understandable and useful for patients, doctors and decision makers. Thus, this project will also ensure that even if the statistical methods are complex, it must be possible to present the results in a way so that the results are easy to understand for them without a technical background. We will develop statistical methods that help us understand the disease process after a cancer diagnosis and further understand the effect of any risk factors. We will also work with other cancer researchers to use the methods in applied research. We will also develop user-friendly software to enable other researchers to use our methods in their research.
- Improve the quality of statistical methods used to analyze population-based cancer dataSwedish Cancer Society1 januari 2015Estimating survival after a cancer diagnosis using data from population-based cancer registers is important to be able to monitor the development of cancer and identify risk factors associated with prognosis. Sweden has, internationally, cancer register data of very high quality, and an important advantage is the possibility of merging different databases. This leads to more detailed information and enables studies with more complex issues. The increasing complexity and details of data, however, poses some challenges for statistical analysis to ensure that the clinical research questions are answered in the most appropriate manner. In this project we will develop statistical methods that can be used to answer important clinical issues using data from cancer registers. With more detailed information, it is possible to use more advanced statistical methods. However, it is important that the results of these analyzes are communicated in a way that is understandable and useful for patients, doctors and decision makers. Thus, this project will also ensure that even if the statistical methods are complex, it must be possible to present the results in a way so that the results are easy to understand for them without a technical background. We will develop statistical methods that help us understand the disease process after a cancer diagnosis and further understand the effect of any risk factors. We will also work with other cancer researchers to use the methods in applied research. We will also develop user-friendly software to enable other researchers to use our methods in their research.
- Development and application of more flexible and informative statistical methods for analyzing population-based cancer studies.Swedish Cancer Society1 januari 2014Data from cancer registers are often used to assess how many people get a certain cancer diagnosis, how many die from a particular cancer form and the proportion of those who have received a cancer diagnosis that still lives, for example. 5 years after diagnosis. It is of interest to follow changes over time, compare regions (both within the country and internationally) and to identify factors that either increase or decrease the risk of suffering or dying from a particular disease. Within this project, we will develop new statistical methods to be able to answer important clinical research questions when using cancer register data. Increased computer capacity has made it possible to use more sophisticated statistical methods than before. However, it is also of great importance that the results from these methods are presented in a way that is understandable and useful for patients, doctors and decision makers in the healthcare sector. Therefore, we will also attach great importance to developing more effective and insightful ways to present and communicate results from these types of studies. The project combines the development of new static methods and applications of the methods on data from the Swedish quality registers for cancer, to answer important clinical research questions. Cancer patient survival will be analyzed in order to demonstrate to researchers what benefits the new methods have, and to increase understanding of the effect of risk factors on cancer mortality.
- Swedish Research Council1 januari 2014 - 31 december 2017
Anställningar
- Gästprofessor, Medicinsk epidemiologi och biostatistik, Karolinska Institutet, 2023-2027
Handledning
Handledning till doktorsexamen
- Yuliya Leontyeva, Development, extensions and applications of statistical models in population-based studies to estimate loss in expectation of life (LEL) due to cancer., 2019-
- Caroline Weibull, Survivorship in Hodgkin lymphoma : childbearing and treatment-related disease, 2018
- Hannah Bower, Flexible parametric models for cancer patient survival: loss in expectation of life and further developments, 2018
- Sandra Eloranta, Development and application of statistical methods for population-based cancer patient survival, 2013